Zobrazeno 1 - 10
of 122
pro vyhledávání: '"KA Mulcahy"'
Autor:
Manasherob, Robert1,2 (AUTHOR), Warren, Shay I.1 (AUTHOR), Arora, Prerna1 (AUTHOR), Heo, Lyong3 (AUTHOR), Haddock, Naomi L.4 (AUTHOR), Koliesnik, Ievgen5 (AUTHOR), Furukawa, Diasuke5 (AUTHOR), Otieno-Ayayo, Z. Ngalo6 (AUTHOR), Maloney, William J.1 (AUTHOR), Lowenberg, David W.1 (AUTHOR), Goodman, Stuart B.1,2 (AUTHOR), Amanatullah, Derek F.1,2 (AUTHOR) dfa@stanford.edu
Publikováno v:
Journal of Translational Medicine. 11/19/2024, Vol. 22 Issue 1, p1-19. 19p.
Publikováno v:
Cancer Immunology, Immunotherapy. 49:417-425
The tumour-suppressor gene p53 is pivotal in the regulation of apoptosis, and point mutations within p53 are the commonest genetic alterations in human cancers. Cytotoxic T lymphocytes (CTL) recognise peptide-MHC complexes on the surface of tumour ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8066a1c0de0775c2378de3e9c103778
https://doi.org/10.1007/s002620000137
https://doi.org/10.1007/s002620000137
Autor:
Sheila Rodgers, Marie Marchand, Ian G. Rennie, Francis Brasseur, Robert C. Rees, Kathryn E. Platts, KA Mulcahy, Thierry Boon, Serge Leyvraz, Danielle Liénard, AK Murray, Donata Rimoldi, CA McIntyre
Publikováno v:
International Journal of Cancer. 66:738-742
It has previously been reported that MAGE-1, -2, -3 and -4 genes are expressed in human cancers including cutaneous melanoma. MAGE-1 and MAGE-3 represent targets for specific immunotherapy because they encode peptide antigens which are recognised by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::365ce47cf9008a2b7f8d6ed200a8d362
https://doi.org/10.1002/(sici)1097-0215(19960611)66:6<738::aid-ijc5>3.0.co
https://doi.org/10.1002/(sici)1097-0215(19960611)66:6<738::aid-ijc5>3.0.co
Autor:
Nagarajan, Aravindh1,2 (AUTHOR), Scoggin, Kristin1,2 (AUTHOR), Adams, L. Garry3 (AUTHOR), Threadgill, David1,4,5,6 (AUTHOR), Andrews-Polymenis, Helene1,2 (AUTHOR) handrews@tamu.edu
Publikováno v:
PLoS Genetics. 8/23/2024, Vol. 20 Issue 8, p1-21. 21p.
Autor:
Ong, Siew Chin1 siewchinong@usm.my, Tay, Lyn Xuan1, Yee, Teck Fah2, Teh, Ewe Eow3, Ch'ng, Alan Swee Hock4, Razali, Rizah Mazzuin5, Lim, Wan Chieh6, Zam, Ungku Ahmad Ameen Bin Ungku Mohd.7, Parumasivam, Thaigarajan8
Publikováno v:
Scientific Reports. 8/15/2024, Vol. 14 Issue 1, p1-12. 12p.
Publikováno v:
Melanoma research. 12(2)
Although the transfection of the T-cell costimulatory molecule CD80 cDNA into human tumours can augment their immunogenicity in vitro, its expression alone is ineffective in many tumour systems. We evaluated the influence of CD80 expression on the im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::799cb5c7e40f4b592e240f93d101d7c7
https://pubmed.ncbi.nlm.nih.gov/11930109
https://pubmed.ncbi.nlm.nih.gov/11930109
Publikováno v:
Cancer immunology, immunotherapy : CII. 42(4)
The MAGE gene family of tumour antigens are expressed in a wide variety of human cancers. We have identified 43 nonamer peptide sequences, from MAGE-1, -2 and -3 proteins that contain binding motifs for HLA-A3 MHC class I molecules. The T2 cell line,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80ab8577e32f248b6fbf68808d216a30
https://pubmed.ncbi.nlm.nih.gov/8665572
https://pubmed.ncbi.nlm.nih.gov/8665572
Publikováno v:
Immunology Letters. 56:163
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5105a16b0cd7b5c581f21614dccb8966
https://doi.org/10.1016/s0165-2478(97)85651-9
https://doi.org/10.1016/s0165-2478(97)85651-9
Autor:
Hajam, Irshad Ahmed, Tsai, Chih-Ming, Gonzalez, Cesia, Caldera, Juan Raphael, Lázaro Díez, María, Du, Xin, Aralar, April, Lin, Brian, Duong, William, Liu, George Y.
Publikováno v:
Nature Communications; 12/16/2024, Vol. 15 Issue 1, p1-16, 16p
Autor:
Korshoj, Lee E., Kielian, Tammy
Publikováno v:
Nature Communications; 11/23/2024, Vol. 15 Issue 1, p1-25, 25p